Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why not buy RIOT instead of HIVE. Don't think that because the price is less that you can make more $$$$$$
Impressive research, are you an analyst or an accountant? What is your confidence level in those numbers? TGOD constantly disappoints
sounds great BUT what is holding it back?
Trust in Frank, there is no one else
It is all about trust
RED FLAG!!!!!!
Can't post financials on time, no excuse!
SPLIF is trading @.125
Thanks, now I get it!!
why can't I trust Frank?
Toronto, Ontario--(Newsfile Corp. - November 12, 2021) - Nutritional High International Inc. (CSE: FUZN) (OTCQB: SPLIF) (the "Company") announced today that its common shares remain halted pending the filing of articles of amendment to give effect to its name change from "Nutritional High International Inc." to "High Fusion Inc." (the "Name Change"), the reclassification of its common shares to "subordinate voting shares" (the "Share Reclassification") and the creation of a new class of shares called "multiple voting shares".
The Company has been unable to file the articles of amendment due to a technical issue with the Company's access to Corporation Canada's online filing platform. The Company is working to resolve the issue as quickly as possible.
Once the articles are filed the multiple voting shares will be nearly identical to the subordinate voting shares but for the fact that each multiple voting share will carry the right to ten votes per share and have the economic equivalent of ten subordinate voting shares. The multiple voting shares are being created in connection with the Company's acquisition of substantially all the assets of OutCo Labs Inc. Pursuant to the acquisition, the multiple voting shares are being created in order to minimize the proportion of the outstanding voting securities of the Company that are held by "U.S. persons" for purposes of determining whether the Company is a "foreign private issuer" pursuant to United States securities laws. Further information about the Share Reclassification is available in the Company's information circular dated August 17, 2021, which is available under the Company's SEDAR profile at www.sedar.com.
The CUSIP number assigned to the subordinate voting shares following the Name Change and Share Reclassification will be: CUSIP 42967W102 (ISIN CA42967W1023).
In connection with the Name Change and Share Reclassification, the trading symbol for the subordinate voting shares trading on the Canadian Securities Exchange has been changed from "EAT" to "FUZN".
Thank you, that is very helpful info.
Is there a new symbol, the stock has not traded for a couple of days?
link please
Thanks for the info
WTF happened?
Excellent info, now the question is Revenues and Profitability
That would be fabulous
Seems to me that nobody knows anything about this company. An offer to an unnamed company? Financials? Corporate office location(other than a private house)? WHERE'S THE BEEF?
1.3M to sell
Almost zero volume. All it will take is a little push for a major gain.
I have never seen that wording before. What about alleged revenue as well. Facts are real, all else is BS.
my final post. From the PR
submitted a non-binding purchase offer for a California-based consumer products company with multiple existing products, revenue and alleged profits. What exactly are alleged profits?
Can somebody show me a picture of corporate headquarters? You can find it if you try.
Companies normally do not announce offers to unknown companies unless they want to pump the SP. BTW, where are the financials?
Since when do companies announce an offer via twitter? I do not trust this company but that is only my opinion. LOL
HUT8 not where I would go, maybe MARA. The question I have is: Do you really under the business and possible negatives such as Enormous energy needs? I don't so I pass.
I agree totally
something fishy going on that is keeping the SP down
Eventually it happens
stock manipulation runs rampant in the market, been going on for decades.
There is a reason for the selloff, I just don't know what it is. Wish I did.
Meet The Top 12 CEOs In The Psychedelics Industry
12:46 pm ET September 13, 2021 (Benzinga) Print
By Natan Ponieman and Javier Hasse
The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate leaders, working to create new methods for the treatment of mental health and other serious conditions.
Running an early-stage biotechnology company while navigating the terrain of regulatory approvals is a tough business. Here’s a list of the psychedelic medicine industry’s top CEOs.
Psychedelic Industry CEOs
Rob Barrow: MindMed
Florian Brand: Atai Life Sciences
Doug Drysdale: Cybin
Joseph del Moral: Field Trip Health
George Goldsmith: Compass Pathways
Payton Nyquvest: Numinus
Dr. Joseph Tucker: MagicMed
Dr. Roger McIntyre: Braxia Health
Kelsey Ramsden: MindCure
Yaron Conforti: Novamind
Daniel Carcillo: Wesana Health
Raj Mehra: Seelos Therapeutics
Rob Barrow: MindMed
Mind Medicine Inc. (NASDAQ: MNMD), also known as MindMed, is an industry leader. One of the first psychedelic medicine companies to go public, MindMed has a diverse development pipeline, impressive team and a loyal base of passionate investors. From LSD, to MDMA, to DMT, MindMed is working to treat everything from opioid addiction to headaches to ADHD.
Rob Barrow is MindMed’s new CEO. A pharmaceutical executive and pharmacologist, Barrow has a wealth of experience leading drug development teams and navigating the pharmaceutical approval landscape. Barrow previously served as Director at the Usona Institute, where he managed the clinical and regulatory efforts focused on psychedelics. Taking over from founder and former CEO JR Rahn, Barrow seems a good fit to lead MindMed into its next stage of development.
HIVE is the new symbol
excellent DD, very helpful
I hear the optimism so who is doing all the selling and why?
How can cannabis remain schedule 1. It has been clearly proven to have medicinal benefits. Maybe when the politicians figure out how to benefit from it they will reschedule it.
If they don't it is game over but the intention is to build a real company. I am cautiously optimistic. Watch the volume!
Usually viewed negatively but could present a buying opportunity over the next few days